查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2134003

體外診斷（IVD）人工智慧（AI）市場：按組件、診斷類型、模式、技術、最終用戶、國家和地區分類－全球產業分析、市場規模、市場佔有率及2026-2033年預測

Artificial Intelligence in IVD Market, By Component, By Diagnosis Type, By Modality, By Technology, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 333 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，體外診斷 (IVD) 領域的人工智慧 (AI) 市場價值將達到 5.103 億美元，並預計從 2026 年到 2033 年將以 20.9% 的複合年成長率成長。

體外診斷（IVD）中的人工智慧涵蓋演算法、機器學習軟體、計算病理學、智慧檢查室資訊學以及人工智慧驅動的分析工作流程，用於解讀或輔助解讀從患者檢體中獲得的結果。與傳統IVD主要依賴檢測方法和儀器的化學特性不同，人工智慧增加了一層計算處理能力，能夠識別模式、整合多模態數據、確定病例優先順序並輔助診斷。因此，該生態系統涵蓋了病理學、分子診斷、血液學及相關工作流程中的實驗室儀器、軟體平台、資料基礎設施、檢驗、部署和生命週期服務。到2025年，美國食品藥物管理局（FDA）已批准超過1300種人工智慧驅動的醫療設備，顯示臨床人工智慧技術的監管已日趨成熟。這正推動市場從獨立演算法轉向整合化的、臨床管理的診斷工作流程。

體外診斷中的人工智慧—市場動態

多模態診斷數據與人工智慧輔助臨床工作流程的整合

將日益分散的診斷資訊轉化為可操作的臨床見解的需求，是推動市場發展的動力。儘管檢測結果、病理影像、基因組分析結果和臨床記錄很少被單獨分析，造成工作流程瓶頸，但人工智慧驅動的自動摘要、模式識別和決策支援有望緩解這些瓶頸。羅氏在2025年診斷日上的演講重點介紹了計算系統如何減輕人工資訊處理的負擔，並展示了人工智慧驅動的摘要工具可以將腫瘤病例摘要所需的時間縮短40-50%。這在體外診斷（IVD）領域尤其明顯，該領域的診斷價值越來越來自於將檢測結果與患者背景資訊結合，而不是產生更多的檢測結果。這表明，對可互通的人工智慧軟體、檢驗的數據管道和人工監督的解讀的需求日益成長。

體外診斷（IVD）中的人工智慧（AI）－市場細分分析：

全球體外診斷人工智慧市場按組件、診斷類型、模式、技術、最終用戶和地區進行細分。

從各個組成部分來看，人工智慧賦能的體外診斷（IVD）的組件正在從單純依賴演算法的形式，轉變為將智慧技術融入整個診斷工作流程的形式。軟體提供演算法解讀、工作流程最佳化、資料整合和決策支援功能。另一方面，硬體提供影像擷取、高通量檢測和人工智慧驅動的處理所需的運算和檢查室基礎設施。服務在檢查室需要檢驗、部署、模型維護、網路安全、互通性和專家支援等方面變得至關重要。例如，PathAI在2025年3月宣布其數位病理平台AISight新增四家實驗室合作夥伴。這表明，軟體主導的生態系統如何將人工智慧功能擴展到多個實驗室環境。因此，組件結構越來越強調整合平台，其中硬體、軟體和持續服務協同運作，構成一個統一的診斷基礎設施。

從診斷類型來看，人工智慧在診斷應用的需求因診斷類型而異。這是因為其基礎證據範圍廣泛，涵蓋影像、生理訊號以及從組織中提取的分子資訊。高容量影像分析和自動檢測對放射學和胸肺影像學有正面影響。心血管測量數據的定量解讀對循環系統至關重要。神經科需要對複雜的圖像和臨床資料集進行模式識別。在腫瘤學中，病理學、生物標記和分子資訊的關聯對於精準治療決策的重要性日益凸顯。這一趨勢也反映在中國截至2025年6月核准的人工智慧設備。在154種核准的人工智慧醫療設備中，68.8%與放射學相關，而循環系統相關設備僅佔10.4%。這種分佈表明，數據豐富且高度結構化的診斷工作流程是目前人工智慧應用的最堅實基礎。

體外診斷中的人工智慧—區域分析

由於美國擁有相對成熟的監管和臨床技術生態系統，因此在人工智慧診斷技術市場中處於領先地位。 2025年，FDA在人工智慧生命週期管理、預先設定的變更管理機制、上市後性能考量以及人工智慧醫療設備授權方面的努力，為開發者提供了更清晰的指南，幫助他們迭代改進軟體。光是FDA於2025年發布的CDRH/OCE報告就列出了26項體外診斷（IVD）核准，其中包括伴隨診斷的新增和擴展適應症。對於體外診斷領域的人工智慧而言，這一點尤其重要，因為其演算法必須與檢驗的檢測方法、病理工作流程和臨床決策流程相容。受監管的人工智慧開發與成熟的伴隨診斷環境的整合至關重要。因此，美國的競爭焦點正從單純的演算法能力轉向經臨床檢驗的整合。

中國正成為另一個成長中心，其特點是人工智慧醫療設備的研發、國內技術供應商的湧現以及監管流程的日益系統化。根據截至2025年6月的核准情況調查，2025年上半年共有20款人工智慧醫療設備獲得核准，其中診斷放射學仍是最常見的應用領域。中國的法規環境也朝著更清楚地界定人工智慧醫療設備的生命週期管理方向發展。國家藥品監督管理局（NMPA）2025年的措施提出了更精細的審查要求，例如考慮多疾病應用和大規模人工智慧模型的應用，以及在核心演算法未發生變更的情況下簡化修改程序。在體外診斷（IVD）人工智慧領域，這種環境更有利於那些能夠進行本地檢驗、遵守法規並進入中國快速發展的診斷技術生態系統的公司，而不是那些僅僅依靠模型性能競爭的公司。

目錄

第1章：體外診斷人工智慧（AI）市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：體外診斷人工智慧（AI）市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：體外診斷人工智慧（AI）產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：體外診斷（IVD）領域的人工智慧（AI）市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：體外診斷人工智慧（AI）市場現狀

  • 2025年體外診斷（IVD）領域人工智慧（AI）市場佔有率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章：體外診斷人工智慧（AI）市場：按組件分類

  • 概述
    • 基於細分市場的市場佔有率分析：按組件
    • 硬體
    • 軟體
    • 服務

第8章：體外診斷人工智慧（AI）市場：按診斷類型分類

  • 概述
    • 細分市場佔有率分析：依診斷類型
    • 放射科
    • 循環系統
    • 胸部和肺部
    • 神經科
    • 腫瘤學
    • 其他

第9章：體外診斷人工智慧（AI）市場：按模式分類

  • 概述
    • 基於細分市場的市佔率分析：依治療方式
    • 診斷影像
    • 體外診斷（IVD）
    • 其他

第10章：體外診斷人工智慧（AI）市場：按技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 自然語言處理
    • 深度學習
    • 電腦視覺
    • 機器學習
    • 預測分析

第11章：體外診斷人工智慧（AI）市場：按最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 門診手術中心
    • 醫院
    • 診斷檢查室
    • 其他

第12章：體外診斷人工智慧（AI）市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第13章 主要供應商分析：體外診斷（IVD）領域的人工智慧（AI）產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Roche Diagnostics
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Danaher Corporation（including Beckman Coulter）
    • Siemens Healthineers
    • Sysmex Corporation
    • bioMerieux
    • Becton Dickinson
    • Bio-Rad Laboratories
    • Shenzhen Mindray Bio-Medical
    • QIAGEN
    • Illumina
    • Hologic
    • PerkinElmer
    • Others

第14章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7467

Artificial Intelligence in IVD Market size was valued at US$ 510.3 Million in 2025, expanding at a CAGR of 20.9% from 2026 to 2033.

Artificial Intelligence in IVD includes algorithms, machine-learning software, computational pathology, intelligent laboratory informatics, and AI-enabled analytical workflows to interpret or support results generated from patient specimens. In contrast to traditional IVD, where measurements are primarily based on assay chemistry and instrumentation, AI adds a computational layer that can recognize patterns, integrate multimodal data, prioritize cases, and support diagnosis. Thus, the ecosystem includes laboratory instruments, software platforms, data infrastructure, validation, implementation, and lifecycle services across pathology, molecular diagnostics, hematology, and related workflows. In 2025, the U.S. FDA approved over 1,300 AI-enabled medical devices, a testament to the regulatory maturity surrounding clinical AI technologies. This is driving the market away from stand-alone algorithms and toward integrated, clinically governed diagnostic workflows.

Artificial Intelligence in IVD Market- Market Dynamics

Convergence of Multimodal Diagnostic Data With AI-Assisted Clinical Workflows

The need to translate increasingly fragmented diagnostic information into clinical intelligence that can be used is a key market driver. Laboratory results, pathology images, genomic findings, and clinical records are rarely analyzed in isolation, causing bottlenecks in workflow that AI may alleviate through automated summarization, pattern recognition, and decision support. Roche's 2025 Diagnostics Day materials pointed out how computational systems can lower the manual information-processing requirements, noting a 40-50% reduction in the time to summarize oncology cases with an AI-enabled abstraction tool. This is especially true for IVD, where the diagnostic value increasingly derives from integrating assay outputs with contextual patient information rather than producing a further laboratory result. This implies an increased need for interoperable AI software, verified data pipelines, and human-supervised interpretation.

Artificial Intelligence in IVD Market- Segmentation Analysis:

The Global Artificial Intelligence in IVD Market is segmented on the basis of Component, Diagnosis Type, Modality, Technology, End User, and Region.

By component, components in AI-enabled IVD are shifting from being driven solely by the algorithm to being determined by how intelligence is embedded across the entire diagnostic workflow. Software provides algorithmic interpretation, workflow orchestration, data integration, and decision-support functionality; hardware supplies the computational and laboratory infrastructure for image acquisition, high-throughput testing, and AI-enabled processing. Where labs need validation, implementation, model maintenance, cybersecurity, interoperability, and specialist support, services become important. For example, PathAI announced in March 2025 its expansion of the AISight digital pathology platform with four new laboratory partners, demonstrating how software-led ecosystems can scale AI capabilities across multiple laboratory environments. The component structure, therefore, increasingly favors integrated platforms in which hardware, software, and ongoing services work together as a coordinated diagnostic infrastructure.

By diagnosis type, diagnostic applications differ significantly in their AI needs by diagnosis type, as the underlying evidence ranges from images and physiological signals to molecular information extracted from tissue. High-volume image analysis and automated detections have positive effects on radiology and chest and lung imaging. Quantitative interpretation of cardiovascular measurements is essential for cardiology. Pattern recognition is required in complex imaging and clinical datasets in neurology. Oncology increasingly relates pathology, biomarkers, and molecular information for precision treatment decisions. This concentration is reflected in the AI devices approved in China through June 2025: 68.8% of 154 approved AI-based medical devices were related to radiology, compared to 10.4% for cardiology. The distribution suggests that data-rich and highly structured diagnostic workflows are the strongest base for AI deployment today.

Artificial Intelligence in IVD Market- Geographical Insights

The United States is leading market because AI-enabled diagnostics are being developed in a relatively mature regulatory and clinical-technology ecosystem. In 2025, the FDA's work on AI lifecycle management, predetermined change control mechanisms, post-market performance considerations, and authorization of AI-enabled devices provided more clarity to developers about how to iteratively improve their software. In just the 2025 CDRH/OCE report from the FDA, there were 26 IVD authorizations, including new and expanded companion-diagnostic indications. This is especially true in the case of AI in IVD, where algorithms must be compatible with validated assays, pathology workflows, and clinical decision processes. The confluence of regulated AI development and an established companion-diagnostics environment is especially important. Thus, U.S. competition is turning more to clinically validated integration, and away from just algorithmic capability.

China is a separate growth center, with a focused development of AI devices, domestic technology suppliers, and an increasingly structured regulatory pathway. A study of approvals through June 2025 revealed 20 AI-based medical-device approvals in the first half of 2025, with radiology continuing as the most common application area. The country's regulatory environment is also leaning toward more explicit lifecycle management of AI-powered medical devices. The NMPA's 2025 measures called for more refined review requirements, including consideration of multi-disease and large-model AI applications and simplified changes where core algorithms are unchanged. In the IVD AI space, this environment benefits companies that can validate locally, work through the regulations, and plug into China's fast-growing diagnostic technology ecosystem more than those competing on model performance alone.

Artificial Intelligence in IVD Market- Competitive Landscape:

Competitive positioning is now based on the capacity to combine diagnostic hardware, knowledge of assays, AI algorithms, clinical validation, and laboratory workflow infrastructure. Roche and Leica Biosystems, part of Danaher, offer well-established IVD and pathology platforms, whereas companies such as PathAI and Tempus provide algorithmic and computational capabilities. Roche's approach to partnering in the field shows how important it is to build an ecosystem: the company announced 75 new diagnostic agreements in 2025, highlighting collaboration as a way of expanding its digital and AI capabilities. On the product side, Roche has incorporated AI into computational pathology and companion diagnostics, and Danaher's 2025 partnership with AstraZeneca was specifically aimed at digital and computational pathology and AI-assisted algorithms. The source of competitive advantage is therefore moving toward integrated, validated AI-diagnostic platforms that have scalable laboratory connectivity.

Recent Developments:

In April 2025, Roche was granted FDA Breakthrough Device Designation for the VENTANA TROP2 RxDx Device. This device uses AI for pathology and helps diagnose non-small cell lung cancer. It was the first time an FDA Breakthrough Device Designation was awarded to a computational pathology companion diagnostic device.

In June 2025, PathAI received FDA clearance for AISight Dx, a pathology platform that assists with primary diagnoses. The clearance also included a Predetermined Change Control Plan, known as PCCP, which allows PathAI to add approved updates to the platform in the future.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Roche Diagnostics
  • Abbott Laboratories
  • Thermo Fisher Scientific
  • Danaher Corporation (including Beckman Coulter)
  • Siemens Healthineers
  • Sysmex Corporation
  • bioMerieux
  • Becton Dickinson
  • Bio-Rad Laboratories
  • Shenzhen Mindray Bio-Medical
  • QIAGEN
  • Illumina
  • Hologic
  • PerkinElmer
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY COMPONENT- MARKET ANALYSIS, 2020 - 2033

  • Hardware
  • Software
  • Services

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY DIAGNOSIS TYPE- MARKET ANALYSIS, 2020 - 2033

  • Radiology
  • Cardiology
  • Chest and Lungs
  • Neurology
  • Oncology
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY MODALITY- MARKET ANALYSIS, 2020 - 2033

  • Diagnostic Imaging
  • In Vitro Diagnostics
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Natural Language Processing
  • Deep Learning
  • Computer Vision
  • Machine Learning
  • Predictive Analytics

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

  • Ambulatory Surgery Centers
  • Hospitals
  • Diagnostic Laboratories
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN IVD MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in IVD Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in IVD Market Snippet by Component
    • 2.1.2. Artificial Intelligence in IVD Market Snippet by Diagnosis Type
    • 2.1.3. Artificial Intelligence in IVD Market Snippet by Modality
    • 2.1.4. Artificial Intelligence in IVD Market Snippet by Technology
    • 2.1.5. Artificial Intelligence in IVD Market Snippet by End User
    • 2.1.6. Artificial Intelligence in IVD Market Snippet by Country
    • 2.1.7. Artificial Intelligence in IVD Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in IVD Key Market Trends

  • 3.1. Artificial Intelligence in IVD Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in IVD Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in IVD Market Opportunities
  • 3.4. Artificial Intelligence in IVD Market Future Trends

4. Artificial Intelligence in IVD Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in IVD Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Artificial Intelligence in IVD Market Landscape

  • 6.1. Artificial Intelligence in IVD Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in IVD Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2025 & 2033 (%)
    • 7.1.2. Hardware
    • 7.1.3. Software
    • 7.1.4. Services

8. Artificial Intelligence in IVD Market - By Diagnosis Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Diagnosis Type, 2025 & 2033 (%)
    • 8.1.2. Radiology
    • 8.1.3. Cardiology
    • 8.1.4. Chest and Lungs
    • 8.1.5. Neurology
    • 8.1.6. Oncology
    • 8.1.7. Others

9. Artificial Intelligence in IVD Market - By Modality

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Modality, 2025 & 2033 (%)
    • 9.1.2. Diagnostic Imaging
    • 9.1.3. In Vitro Diagnostics
    • 9.1.4. Others

10. Artificial Intelligence in IVD Market - By Technology

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 10.1.2. Natural Language Processing
    • 10.1.3. Deep Learning
    • 10.1.4. Computer Vision
    • 10.1.5. Machine Learning
    • 10.1.6. Predictive Analytics

11. Artificial Intelligence in IVD Market - By End User

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
    • 11.1.2. Ambulatory Surgery Centers
    • 11.1.3. Hospitals
    • 11.1.4. Diagnostic Laboratories
    • 11.1.5. Others

12. Artificial Intelligence in IVD Market- By Geography

  • 12.1. Introduction
    • 12.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 12.2. North America
    • 12.2.1. Overview
    • 12.2.2. Artificial Intelligence in IVD Key Manufacturers in North America
    • 12.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.2.4. North America Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.2.5. North America Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
    • 12.2.6. North America Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
    • 12.2.7. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.2.8. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.9. U.S.
      • 12.2.9.1. Overview
      • 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.9.3. U.S. Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.9.4. U.S. Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.2.9.5. U.S. Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.2.9.6. U.S. Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.9.7. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.2.10. Canada
      • 12.2.10.1. Overview
      • 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.2.10.3. Canada Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.2.10.4. Canada Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.2.10.5. Canada Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.2.10.6. Canada Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.2.10.7. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.3. Europe
    • 12.3.1. Overview
    • 12.3.2. Artificial Intelligence in IVD Key Manufacturers in Europe
    • 12.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.3.4. Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.3.5. Europe Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
    • 12.3.6. Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
    • 12.3.7. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.3.8. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.9. Germany
      • 12.3.9.1. Overview
      • 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.9.3. Germany Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.9.4. Germany Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.9.5. Germany Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.9.6. Germany Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.9.7. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.10. UK
      • 12.3.10.1. Overview
      • 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.10.3. UK Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.10.4. UK Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.10.5. UK Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.10.6. UK Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.10.7. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.11. France
      • 12.3.11.1. Overview
      • 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.11.3. France Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.11.4. France Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.11.5. France Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.11.6. France Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.11.7. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.12. Italy
      • 12.3.12.1. Overview
      • 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.12.3. Italy Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.12.4. Italy Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.12.5. Italy Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.12.6. Italy Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.12.7. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.13. Spain
      • 12.3.13.1. Overview
      • 12.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.13.3. Spain Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.13.4. Spain Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.13.5. Spain Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.13.6. Spain Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.13.7. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.14. The Netherlands
      • 12.3.14.1. Overview
      • 12.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.14.3. The Netherlands Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.14.4. The Netherlands Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.14.5. The Netherlands Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.14.6. The Netherlands Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.14.7. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.15. Sweden
      • 12.3.15.1. Overview
      • 12.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.15.3. Sweden Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.15.4. Sweden Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.15.5. Sweden Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.15.6. Sweden Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.15.7. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.16. Russia
      • 12.3.16.1. Overview
      • 12.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.16.3. Russia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.16.4. Russia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.16.5. Russia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.16.6. Russia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.16.7. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.17. Poland
      • 12.3.17.1. Overview
      • 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.17.3. Poland Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.17.4. Poland Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.17.5. Poland Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.17.6. Poland Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.17.7. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.18. Denmark
      • 12.3.18.1. Overview
      • 12.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.18.3. Denmark Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.18.4. Denmark Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.18.5. Denmark Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.18.6. Denmark Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.18.7. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.3.19. Rest of Europe
      • 12.3.19.1. Overview
      • 12.3.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.3.19.3. Rest of the Europe Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.3.19.4. Rest of the Europe Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.3.19.5. Rest of the Europe Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.3.19.6. Rest of the Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.3.19.7. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.4. Asia Pacific (APAC)
    • 12.4.1. Overview
    • 12.4.2. Artificial Intelligence in IVD Key Manufacturers in Asia Pacific
    • 12.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.4.4. APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.4.5. APAC Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
    • 12.4.6. APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
    • 12.4.7. APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.4.8. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.9. China
      • 12.4.9.1. Overview
      • 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.9.3. China Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.9.4. China Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.9.5. China Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.9.6. China Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.9.7. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.10. India
      • 12.4.10.1. Overview
      • 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.10.3. India Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.10.4. India Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.10.5. India Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.10.6. India Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.10.7. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.11. Japan
      • 12.4.11.1. Overview
      • 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.11.3. Japan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.11.4. Japan Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.11.5. Japan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.11.6. Japan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.11.7. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.12. South Korea
      • 12.4.12.1. Overview
      • 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.12.3. South Korea Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.12.4. South Korea Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.12.5. South Korea Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.12.6. South Korea Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.12.7. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.13. Australia
      • 12.4.13.1. Overview
      • 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.13.3. Australia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.13.4. Australia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.13.5. Australia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.13.6. Australia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.13.7. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.14. Indonesia
      • 12.4.14.1. Overview
      • 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.14.3. Indonesia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.14.4. Indonesia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.14.5. Indonesia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.14.6. Indonesia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.14.7. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.15. Thailand
      • 12.4.15.1. Overview
      • 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.15.3. Thailand Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.15.4. Thailand Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.15.5. Thailand Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.15.6. Thailand Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.15.7. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.16. Philippines
      • 12.4.16.1. Overview
      • 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.16.3. Philippines Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.16.4. Philippines Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.16.5. Philippines Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.16.6. Philippines Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.16.7. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.17. Taiwan
      • 12.4.17.1. Overview
      • 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.17.3. Taiwan Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.17.4. Taiwan Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.17.5. Taiwan Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.17.6. Taiwan Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.17.7. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.18. Vietnam
      • 12.4.18.1. Overview
      • 12.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.18.3. Vietnam Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.18.4. Vietnam Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.18.5. Vietnam Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.18.6. Vietnam Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.18.7. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.4.19. Rest of APAC
      • 12.4.19.1. Overview
      • 12.4.19.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.4.19.3. Rest of APAC Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.4.19.4. Rest of APAC Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.4.19.5. Rest of APAC Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.4.19.6. Rest of APAC Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.4.19.7. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.5. Latin America (LATAM)
    • 12.5.1. Overview
    • 12.5.2. Artificial Intelligence in IVD Key Manufacturers in Latin America
    • 12.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.5.4. LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.5.5. LATAM Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
    • 12.5.6. LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
    • 12.5.7. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.5.8. LATAM Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.9. Brazil
      • 12.5.9.1. Overview
      • 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.9.3. Brazil Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.9.4. Brazil Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.5.9.5. Brazil Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.5.9.6. Brazil Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.9.7. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.10. Mexico
      • 12.5.10.1. Overview
      • 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.10.3. Mexico Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.10.4. Mexico Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.5.10.5. Mexico Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.5.10.6. Mexico Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.10.7. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.11. Argentina
      • 12.5.11.1. Overview
      • 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.11.3. Argentina Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.11.4. Argentina Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.5.11.5. Argentina Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.5.11.6. Argentina Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.11.7. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.12. Colombia
      • 12.5.12.1. Overview
      • 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.12.3. Colombia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.12.4. Colombia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.5.12.5. Colombia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.5.12.6. Colombia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.12.7. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.5.13. Rest of LATAM
      • 12.5.13.1. Overview
      • 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.5.13.3. Rest of LATAM Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.5.13.4. Rest of LATAM Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.5.13.5. Rest of LATAM Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.5.13.6. Rest of LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
  • 12.6. Middle East and Africa
    • 12.6.1. Overview
    • 12.6.2. Artificial Intelligence in IVD Key Manufacturers in Middle East and Africa
    • 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 12.6.4. Middle East and Africa Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
    • 12.6.5. Middle East and Africa Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
    • 12.6.6. Middle East and Africa Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
    • 12.6.7. Middle East and Africa Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.9. Saudi Arabia
      • 12.6.9.1. Overview
      • 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.9.3. Saudi Arabia Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.9.4. Saudi Arabia Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.9.5. Saudi Arabia Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.9.6. Saudi Arabia Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.10. United Arab Emirates
      • 12.6.10.1. Overview
      • 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.10.3. United Arab Emirates Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.10.4. United Arab Emirates Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.10.5. United Arab Emirates Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.10.6. United Arab Emirates Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.11. Israel
      • 12.6.11.1. Overview
      • 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.11.3. Israel Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.11.4. Israel Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.11.5. Israel Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.11.6. Israel Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.11.7. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.12. Turkey
      • 12.6.12.1. Overview
      • 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.12.3. Turkey Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.12.4. Turkey Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.12.5. Turkey Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.12.6. Turkey Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.12.7. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.13. Algeria
      • 12.6.13.1. Overview
      • 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.13.3. Algeria Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.13.4. Algeria Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.13.5. Algeria Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.13.6. Algeria Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.13.7. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.14. Egypt
      • 12.6.14.1. Overview
      • 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.14.3. Egypt Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.14.4. Egypt Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.14.5. Egypt Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.14.6. Egypt Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.14.7. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.15. Iran
      • 12.6.15.1. Overview
      • 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.15.3. Iran Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.15.4. Iran Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.15.5. Iran Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.15.6. Iran Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.15.7. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.16. Qatar
      • 12.6.16.1. Overview
      • 12.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.16.3. Qatar Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.16.4. Qatar Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.16.5. Qatar Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.16.6. Qatar Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.16.7. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
    • 12.6.17. Rest of MEA
      • 12.6.17.1. Overview
      • 12.6.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 12.6.17.3. Rest of MEA Market Size and Forecast, By Component, 2020 - 2033 (US$ Million)
      • 12.6.17.4. Rest of MEA Market Size and Forecast, By Diagnosis Type, 2020 - 2033 (US$ Million)
      • 12.6.17.5. Rest of MEA Market Size and Forecast, By Modality, 2020 - 2033 (US$ Million)
      • 12.6.17.6. Rest of MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
      • 12.6.17.7. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)

13. Key Vendor Analysis- Artificial Intelligence in IVD Industry

  • 13.1. Competitive Benchmarking
    • 13.1.1. Competitive Dashboard
    • 13.1.2. Competitive Positioning
  • 13.2. Company Profiles
    • 13.2.1. Roche Diagnostics
    • 13.2.2. Abbott Laboratories
    • 13.2.3. Thermo Fisher Scientific
    • 13.2.4. Danaher Corporation (including Beckman Coulter)
    • 13.2.5. Siemens Healthineers
    • 13.2.6. Sysmex Corporation
    • 13.2.7. bioMerieux
    • 13.2.8. Becton Dickinson
    • 13.2.9. Bio-Rad Laboratories
    • 13.2.10. Shenzhen Mindray Bio-Medical
    • 13.2.11. QIAGEN
    • 13.2.12. Illumina
    • 13.2.13. Hologic
    • 13.2.14. PerkinElmer
    • 13.2.15. Others

14. 360 Degree Analyst View

15. Appendix

  • 15.1. Research Methodology
  • 15.2. References
  • 15.3. Abbreviations
  • 15.4. Disclaimer
  • 15.5. Contact Us